Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells

Erstveröffentlichung

2022

Authors

Deissler, Heidrun L.

Rehak, Matus

Busch, Catharina

Wolf, Armin

Wissenschaftlicher Artikel

Published in

Experimental Eye Research ; 216 (2022). - Art.-Nr. 108945. - ISSN 0014-4835. - eISSN 1096-0007

Link to publication

https://dx.doi.org/10.1016/j.exer.2022.108945

Institutions

UKU. Klinik für Augenheilkunde

Subject headings

[Free subject headings]: Retinal endothelial cells | Brolucizumab | Ranibizumab | Aflibercept | VEGF-A | Transcellular flow | Paracellular flow | Transcytosis | Barrier stability | Tight junction | Cell adhesion | Plasmalemma vesicle-associated protein | VESICLE-ASSOCIATED PROTEIN | GROWTH-FACTOR | MACULAR EDEMA | DIABETIC-RETINOPATHY | VASCULAR-PERMEABILITY | MANAGEMENT | BEVACIZUMAB | MIGRATION
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record